CSIS WARRANT SERIES I vs Diagnos Laboratorium Utama Tbk. — how do they compare? CSIS WARRANT SERIES I trades at Rp87 (market cap 4.6B, 5.1K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.6K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 67× CSIS WARRANT SERIES I's market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (129.6K versus 5.1K). Which is the better fit depends on your goals.
| CSIS-W | DGNS | |
|---|---|---|
Market Cap | 4.6B | 308B |
Volume | 5.1K | 129.6K |
Lot | 51 | 1.3K |
Turnover | 435.6K | 28.71M |
Average Price | 85.41 | 221.54 |
Value | 435.6K | 28.71M |
Indicative Equilibrium Price | — | 230 |
Indicative Equilibrium Volume | — | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.
Read more on CSIS-W →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →